Table 2.
Baseline characteristics and surgical aspects of the included patients per group.
| Laparoscopy and ERAS care (n = 16) | Laparoscopy and standard care (n = 16) | P value | |
|---|---|---|---|
| Age, year, median (IQR) | 31.5 (29.25, 43.50) | 29.5 (26.25, 43.50) | NS |
| Course of disease, month median (IQR) | 32 (12, 81) | 42 (10.5, 81) | NS |
| Male sex, n (%) | 9 (56.3%) | 11 (68.8%) | NS |
| Body mass index, mean (SD, kg/m2) | 18.09 ± 2.35 | 17.68 ± 1.81 | NS |
| ASA (%), grade I or II | 100 | 100 | NS |
| Smoking history, n (%) | 2 (12.5) | 5 (31.3) | NS |
| Immunosuppressant therapy within 30 days of surgery, n (%) | 0 (0) | 2 (12.5) | NS |
| Steroid therapy within 30 days of surgery, n (%) | 0 (0) | 1 (6.3) | NS |
| Operation history, n (%) | 7 (43.8) | 7 (43.8) | NS |
| Perianal disease, n (%) | 2 (12.5) | 3 (18.8) | NS |
| Location, n (%) | NS | ||
| L1 (ileal) | 13 (81.3) | 12 (75) | |
| L2 (colonic) | 0 | 0 | |
| L3 (ileocolonic) | 3 (18.8) | 4 (25) | |
| Laboratory indices | |||
| White blood cell, mean, (SD, ×109/L) | 5.66 ± 1.75 | 6.21 ± 2.76 | NS |
| Hemoglobin, g/L, median (IQR) | 11.4 (10.58, 12.98) | 12.1 (11.68, 13.78) | NS |
| C-reactive protein, mg/L, median (IQR) | 2.55 (1.025, 10.45) | 3.6 (1.15, 13.325) | NS |
| ESR, mm/h, median (IQR) | 9 (6.25, 16) | 9 (6, 14.75) | NS |
| Albumin, g/L, median (IQR) | 36.85 (34.15, 38.225) | 33.65 (32.15, 32.375) | NS |
| Preoperative thirst, n (%) | 1 (6.3) | 14 (87.5) | <0.001 |
| Preoperative hunger, n (%) | 1 (6.3) | 14 (87.5) | <0.001 |
| Conversion to open, n (%) | 0 | 0 | NS |
| Duration of surgery, minutes, median (IQR) | 162.5 (131.25, 180) | 180 (152.5, 240) | NS |
| Blood loss, mL, median (IQR) | 30 (20, 37.5) | 30 (22.5, 55.5) | NS |
ERAS = enhanced recovery after surgery; IQR = interquartile range; SD = standard deviation; ASA = American Society of Anesthesiologists; ESR = erythrocyte sedimentation rate; NS = not significant.